ESPOSITO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.456
EU - Europa 8.802
AS - Asia 7.816
SA - Sud America 858
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 16
Totale 33.122
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.179
GB - Regno Unito 2.751
IT - Italia 2.430
CN - Cina 2.297
SG - Singapore 2.258
SE - Svezia 1.020
HK - Hong Kong 925
VN - Vietnam 734
BR - Brasile 659
DE - Germania 594
UA - Ucraina 443
FI - Finlandia 419
TR - Turchia 409
FR - Francia 292
BD - Bangladesh 273
RU - Federazione Russa 270
KR - Corea 263
IN - India 207
CA - Canada 149
BG - Bulgaria 145
NL - Olanda 105
AR - Argentina 80
MX - Messico 76
ZA - Sudafrica 58
IQ - Iraq 55
LT - Lituania 55
ID - Indonesia 50
PL - Polonia 45
IE - Irlanda 40
PK - Pakistan 40
JP - Giappone 39
IR - Iran 37
AE - Emirati Arabi Uniti 31
ES - Italia 31
BE - Belgio 29
CO - Colombia 28
PH - Filippine 26
EU - Europa 24
EC - Ecuador 23
IL - Israele 23
UZ - Uzbekistan 21
CL - Cile 20
AT - Austria 17
EG - Egitto 17
MY - Malesia 17
JO - Giordania 16
PE - Perù 16
SA - Arabia Saudita 16
CH - Svizzera 15
MA - Marocco 15
VE - Venezuela 14
AU - Australia 13
DZ - Algeria 12
KE - Kenya 12
TH - Thailandia 12
GR - Grecia 10
RO - Romania 10
RS - Serbia 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
JM - Giamaica 9
KZ - Kazakistan 9
PY - Paraguay 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
PA - Panama 8
PT - Portogallo 7
AZ - Azerbaigian 6
HN - Honduras 6
NO - Norvegia 6
SI - Slovenia 6
TN - Tunisia 6
TW - Taiwan 6
AL - Albania 5
ET - Etiopia 5
GE - Georgia 5
KW - Kuwait 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AM - Armenia 4
EE - Estonia 4
LB - Libano 4
MD - Moldavia 4
NP - Nepal 4
QA - Qatar 4
SN - Senegal 4
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
MG - Madagascar 3
NZ - Nuova Zelanda 3
OM - Oman 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
CU - Cuba 2
GT - Guatemala 2
HU - Ungheria 2
Totale 33.089
Salva come PNG Salva come JPEG
Città #
Southend 2.066
Santa Clara 1.596
Singapore 1.485
Ashburn 1.305
Fairfield 1.105
Woodbridge 1.011
Chandler 918
Hong Kong 898
Jacksonville 797
Hefei 787
Houston 676
Dearborn 572
Nyköping 514
Wilmington 493
Beijing 481
Ann Arbor 449
San Jose 394
Seattle 386
Cambridge 374
London 341
Los Angeles 318
Chicago 292
Helsinki 263
Seoul 249
Izmir 245
Milan 232
New York 214
Ho Chi Minh City 213
The Dalles 195
Rome 187
Hanoi 167
Council Bluffs 163
Princeton 147
Sofia 138
Eugene 135
Buffalo 133
Dallas 133
San Diego 119
Salt Lake City 118
Modena 116
Lauterbourg 111
Des Moines 105
Shanghai 95
Frankfurt am Main 88
Naples 86
Moscow 80
São Paulo 68
Tampa 63
Munich 58
Elk Grove Village 52
Orem 49
Da Nang 46
Bologna 44
Toronto 44
Philadelphia 43
Montreal 42
Palermo 41
Columbus 40
Florence 37
Nanjing 37
Bari 36
Warsaw 36
Guangzhou 35
Bremen 34
Haiphong 33
Boardman 32
Dublin 32
Chennai 31
Tokyo 30
Redwood City 29
Kent 28
Mexico City 28
Sterling 28
Mumbai 27
Turin 27
Verona 27
Atlanta 25
Brooklyn 25
Johannesburg 25
Catania 24
Ottawa 24
Brescia 23
Brussels 23
Kunming 23
Amsterdam 22
Augusta 22
Jakarta 22
San Mateo 22
Baghdad 21
Detroit 21
Falkenstein 21
Norwalk 21
Memphis 20
Miano 20
Parma 20
Boston 19
Lancaster 19
Miami 19
Phoenix 19
Rio de Janeiro 19
Totale 22.666
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.761
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 504
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 419
Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients 403
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. 387
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 383
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 361
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study 359
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 356
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients 339
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 338
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 338
Efficacy and safety of atazanavir in patients with end-stage liver disease. 328
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 325
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 323
La clinica metabolica per il trattamento della lipodistrofia 318
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 317
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 315
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 307
Fatal cytomegalovirus necrotising enteritis in a small bowel transplantation adult recipient with low pp65 antigenaemia levels 305
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 305
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 301
Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation. 301
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 301
Gli ascessi epatici nei pazienti sottoposi a trapianto ortotopico di fegato 300
Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. 299
Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation 299
Differential Dose Adjustments of Immunosuppressants after Resuming Boosted versus Unboosted HIV-Protease Inhibitors Postliver Transplant. 298
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 292
Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy 292
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection 290
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 286
Brucellosis in a patient with end-stage liver disease undergoing liver transplantation: successful treatment with tigecycline. 286
Detectable HIV viral load is associated with metabolic syndrome 283
Applicazione della scala di valutazione, Functional indipendence Measure (FIM), per la valutazione dei programmi di riabilitazione per pazienti affetti da AIDS Dementia Complex ospiti di una casa alloggio 281
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 280
Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. 279
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 278
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 277
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: An international observational study 277
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 272
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 271
Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR 271
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation 270
Severity of lipodystrophy is associated with decreased health-related quality of life 269
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 265
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 261
Raltegravir and enfuvirtide as a “bridge” antiretroviral therapy in kidney-tranplanted patients with HIV infection receiving everolimus and low-dose cyclosporine: a case-control study 261
Immunophenotype of HIV plus patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system 257
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 255
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 255
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 255
Age-related comorbidities in people living with HIV 252
Artropodi vettori di agenti infettivi 249
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 246
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 244
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 243
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 243
Improving the appropriateness of antibiotic prescription in hospitals: a pilot study assessing the effectiveness of an infectious diseases specialist's consultation programme 241
Un caso di tubercolosi post-trapianto ortotopico di fegato: limiti dell’impiego del quantiferon-TB gold nella diagnosi della infezione tubercolare latente ed attiva 241
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 239
Bloodstream infections (BSIs) in Liver Transplant Recipients: Analisys at an Italian Tertiary-Care Hospital 238
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 10(6) cells/I 238
Prevalence of secondary causes of osteoporosis among HIV infected individuals 237
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 230
Does lipodistrophy affect quality of life? 225
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 222
Body Image perception in HIV infected women with body fat redistribution. 219
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease 219
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 219
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of quantiferon TB GOLD results in the transplant setting: A case report 218
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 217
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 215
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: The CARe study 212
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) 212
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 209
Determinants of erectile dysfunction changes in HIV infected men: a prospective study. 208
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 207
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 205
Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: Report of three cases 202
Pharmacokinetic interaction between amprenavir/ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation 202
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 199
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: The changes in opportunistic prophylaxis study 197
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 196
È possibile un counselling HIV su internet? 196
GH response to GH-releasing hormone-arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy 196
La trasmissione verticale di HIV nell’era della HAART 195
HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. 193
CD4-Guided treatment interruptions: a new possibile therapeutic strategy 190
Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy 190
Body fat redistribution syndrome in HIV infected people is associated with good adherence to HAART 190
Studio caso-controllo sui fattori di rischio delle infezioni micotiche nei pazienti sottoposti a trapianto ortotopico di fegato (OLT) da donatore cadavere e da donatore vivente. 189
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 189
Validity of body image perception in women with HIV. 188
Pathological fractures in patients with osteopenia and osteoporosis induced by antiretroviral therapy 187
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA 186
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 179
La casa alloggio: ospite, centro riabilitativo o entrambi? 178
Prevalence and risk factors of pubic lipomas in HIV-infected patients 178
Erectile dysfunction does not mirror sub-clinical atherosclerosis in HIV infected males. 177
Totale 27.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 0 0 123
2021/20222.286 31 374 189 246 53 85 118 177 220 134 367 292
2022/20232.854 300 261 229 240 316 467 46 288 333 55 166 153
2023/20241.739 111 139 122 176 283 151 149 199 52 60 104 193
2024/20255.789 219 94 93 387 1.230 791 461 287 658 258 619 692
2025/202610.091 674 477 893 1.237 1.715 756 1.000 489 985 828 633 404
Totale 33.327